283 related articles for article (PubMed ID: 25447675)
21. Transcription repressor activity of spleen tyrosine kinase mediates breast tumor suppression.
Wang L; Devarajan E; He J; Reddy SP; Dai JL
Cancer Res; 2005 Nov; 65(22):10289-97. PubMed ID: 16288017
[TBL] [Abstract][Full Text] [Related]
22. Syk- and Lyn-dependent phosphorylation of Syk on multiple tyrosines following B cell activation includes a site that negatively regulates signaling.
Keshvara LM; Isaacson CC; Yankee TM; Sarac R; Harrison ML; Geahlen RL
J Immunol; 1998 Nov; 161(10):5276-83. PubMed ID: 9820500
[TBL] [Abstract][Full Text] [Related]
23. Spleen tyrosine kinase suppresses osteoblastic differentiation through MAPK and PKCα.
Yoshida K; Higuchi C; Nakura A; Yoshikawa H
Biochem Biophys Res Commun; 2011 Aug; 411(4):774-9. PubMed ID: 21782794
[TBL] [Abstract][Full Text] [Related]
24. Expression of RAC2 in endothelial cells is required for the postnatal neovascular response.
De P; Peng Q; Traktuev DO; Li W; Yoder MC; March KL; Durden DL
Exp Cell Res; 2009 Jan; 315(2):248-63. PubMed ID: 19123268
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of ZAP-70 and Syk protein tyrosine kinases, and the role of this family of protein tyrosine kinases in TCR signaling.
Chan AC; van Oers NS; Tran A; Turka L; Law CL; Ryan JC; Clark EA; Weiss A
J Immunol; 1994 May; 152(10):4758-66. PubMed ID: 8176201
[TBL] [Abstract][Full Text] [Related]
26. CD45 is essential for Fc epsilon RI signaling by ZAP70, but not Syk, in Syk-negative mast cells.
Zhang J; Siraganian RP
J Immunol; 1999 Sep; 163(5):2508-16. PubMed ID: 10452987
[TBL] [Abstract][Full Text] [Related]
27. Complement-mediated phagocytosis--the role of Syk.
Tohyama Y; Yamamura H
IUBMB Life; 2006; 58(5-6):304-8. PubMed ID: 16754322
[TBL] [Abstract][Full Text] [Related]
28. Syk interacts with and phosphorylates nucleolin to stabilize Bcl-x(L) mRNA and promote cell survival.
Wang WH; Childress MO; Geahlen RL
Mol Cell Biol; 2014 Oct; 34(20):3788-99. PubMed ID: 25092868
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of signaling through the B cell antigen receptor by the protooncogene product, c-Cbl, requires Syk tyrosine 317 and the c-Cbl phosphotyrosine-binding domain.
Yankee TM; Keshvara LM; Sawasdikosol S; Harrison ML; Geahlen RL
J Immunol; 1999 Dec; 163(11):5827-35. PubMed ID: 10570266
[TBL] [Abstract][Full Text] [Related]
30. Expression of dominant-negative src-homology domain 2-containing protein tyrosine phosphatase-1 results in increased Syk tyrosine kinase activity and B cell activation.
Dustin LB; Plas DR; Wong J; Hu YT; Soto C; Chan AC; Thomas ML
J Immunol; 1999 Mar; 162(5):2717-24. PubMed ID: 10072516
[TBL] [Abstract][Full Text] [Related]
31. Inducible expression of hyperactive Syk in B cells activates Blimp-1-dependent terminal differentiation.
Hug E; Hobeika E; Reth M; Jumaa H
Oncogene; 2014 Jul; 33(28):3730-41. PubMed ID: 23955076
[TBL] [Abstract][Full Text] [Related]
32. Autoinhibition and adapter function of Syk.
Kulathu Y; Grothe G; Reth M
Immunol Rev; 2009 Nov; 232(1):286-99. PubMed ID: 19909371
[TBL] [Abstract][Full Text] [Related]
33. Swiprosin-1/EFhd2 controls B cell receptor signaling through the assembly of the B cell receptor, Syk, and phospholipase C gamma2 in membrane rafts.
Kroczek C; Lang C; Brachs S; Grohmann M; Dütting S; Schweizer A; Nitschke L; Feller SM; Jäck HM; Mielenz D
J Immunol; 2010 Apr; 184(7):3665-76. PubMed ID: 20194721
[TBL] [Abstract][Full Text] [Related]
34. Syk, but not Lyn, recruitment to B cell antigen receptor and activation following stimulation of CD45- B cells.
Pao LI; Cambier JC
J Immunol; 1997 Mar; 158(6):2663-9. PubMed ID: 9058799
[TBL] [Abstract][Full Text] [Related]
35. Syk: a new player in the field of breast cancer.
Stewart ZA; Pietenpol JA
Breast Cancer Res; 2001; 3(1):5-7. PubMed ID: 11250739
[TBL] [Abstract][Full Text] [Related]
36. Fc gamma receptors differ in their structural requirements for interaction with the tyrosine kinase Syk in the initial steps of signaling for phagocytosis.
Kim MK; Pan XQ; Huang ZY; Hunter S; Hwang PH; Indik ZK; Schreiber AD
Clin Immunol; 2001 Jan; 98(1):125-32. PubMed ID: 11141335
[TBL] [Abstract][Full Text] [Related]
37. Thermodynamic study of the binding of the tandem-SH2 domain of the Syk kinase to a dually phosphorylated ITAM peptide: evidence for two conformers.
Grucza RA; Fütterer K; Chan AC; Waksman G
Biochemistry; 1999 Apr; 38(16):5024-33. PubMed ID: 10213605
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of spleen tyrosine kinase in hepatocellular carcinoma by promoter CpG island hypermethylation and its potential role in carcinogenesis.
Shin SH; Lee KH; Kim BH; Lee S; Lee HS; Jang JJ; Kang GH
Lab Invest; 2014 Dec; 94(12):1396-405. PubMed ID: 25310533
[TBL] [Abstract][Full Text] [Related]
39. Regulation of the pp72syk protein tyrosine kinase by platelet integrin alpha IIb beta 3.
Gao J; Zoller KE; Ginsberg MH; Brugge JS; Shattil SJ
EMBO J; 1997 Nov; 16(21):6414-25. PubMed ID: 9351824
[TBL] [Abstract][Full Text] [Related]
40. The Syk kinase SmTK4 of Schistosoma mansoni is involved in the regulation of spermatogenesis and oogenesis.
Beckmann S; Buro C; Dissous C; Hirzmann J; Grevelding CG
PLoS Pathog; 2010 Feb; 6(2):e1000769. PubMed ID: 20169182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
